A multimodal AI model improved neuroblastoma diagnosis, molecular prediction, and risk stratification using routine pathology ...
Paraneoplastic disease develops in a small proportion of patients with dermatomyositis but occurs mainly among those ...
High-risk APOL1 genotypes are associated with greater long-term kidney dysfunction among Black living donors, suggesting a potential role for genetic screening during donor evaluation.
MedPage Today on MSN
Guidelines help spot dermatomyositis patients at high risk for cancer
IMACS guidelines are clinically useful for identifying high-risk populations, researchers ...
Dr. Monty Pal discusses the historical role of the International Metastatic Renal Cell Database Consortium (IMDC) risk ...
Medical Device Network on MSN
ALZAI reports validation of Alzheimer’s risk identification models
The validation used a HealthVerity dataset with 38 million lab test results and over three million diagnostic records.
The American College of Cardiology released a 2026 scientific statement on antiplatelet therapy for atherosclerotic cardiovascular disease.
Moshe Talpaz, MD: Myelofibrosis has a very heterogeneous course and a very heterogeneous course of outcome. Patients can live anywhere from 1 year to 15 years or longer. And it’s important to ...
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN ...
Pulmonary arterial hypertension (PAH) is a rare, progressive disease of the precapillary pulmonary arteries, characterized by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results